The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis
2005

Fluconazole Use in High-Risk Surgical Patients

Sample size: 814 publication Evidence: moderate

Author Information

Author(s): Ho Kwok M, Lipman Jeffrey, Dobb Geoffrey J, Webb Steven AR

Primary Institution: Royal Perth Hospital, Australia

Hypothesis

Does prophylactic fluconazole reduce the incidence of candidaemia and hospital mortality in immunocompetent high-risk surgical patients?

Conclusion

Prophylactic fluconazole reduces the incidence of candidaemia but shows only a trend towards reducing hospital mortality.

Supporting Evidence

  • Fluconazole was associated with a reduction in candidaemia (RR = 0.21).
  • Fluconazole reduced the need for systemic amphotericin B (RR = 0.35).
  • No significant increase in fluconazole-resistant fungi was observed.

Takeaway

Giving fluconazole to patients at high risk for fungal infections helps lower the chances of getting a specific type of infection called candidaemia.

Methodology

Meta-analysis of randomized controlled trials involving immunocompetent high-risk surgical patients.

Potential Biases

Potential publication bias and variability in trial quality.

Limitations

The study did not include a formal cost-effectiveness analysis and had variability in study protocols.

Participant Demographics

Immunocompetent high-risk surgical patients, mean age around 54 years.

Statistical Information

P-Value

0.01

Confidence Interval

0.06–0.72

Statistical Significance

p=0.01

Digital Object Identifier (DOI)

10.1186/cc3883

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication